Suscribirse

A Meta-analysis of Sleep-promoting Interventions During Critical Illness - 18/09/15

Doi : 10.1016/j.amjmed.2015.05.026 
Chithra Poongkunran, MD a, Santosh G. John, MD a, Arun S. Kannan, MD a, Safal Shetty, MD a, b, Christian Bime, MD a, b, c, Sairam Parthasarathy, MD a, b, c,
a Department of Medicine, University of Arizona, Tucson 
b Division of Pulmonary, Critical Care, and Sleep Medicine, University of Arizona, Tucson 
c Arizona Respiratory Center, University of Arizona, Tucson 

Requests for reprints should be addressed to Sairam Parthasarathy, MD, University of Arizona, 1501 N. Campbell Ave, AHSC Rm 2342D, Tucson, AZ 85724.

Abstract

Background

Sleep quality and quantity are severely reduced in critically ill patients receiving mechanical ventilation with a potential for adverse consequences. Our objective was to synthesize the randomized controlled trials (RCTs) that measured the efficacy of sleep-promoting interventions on sleep quality and quantity in critically ill patients.

Methods

We included RCTs that objectively measured sleep with electroencephalography or its derivatives and excluded observational studies and those that measured sleep by subjective reports. The research was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.

Results

Of 6022 studies identified, 13 met eligibility criteria involving 296 critically ill patients. Eight trials looked at different modes of mechanical ventilation as sleep interventions, and the remaining 5 involved pharmacologic, nonpharmacologic, or environmental interventions. Meta-analysis of the studies revealed that sleep-promoting interventions improved sleep quantity (pooled standardized mean difference [SMD], 0.37; 95% confidence interval [CI], 0.05-0.69; P = .02) and sleep quality through reduction in sleep fragmentation (SMD, −0.31; 95% CI, −0.60 to −0.01; P = .04). Subgroup analysis revealed that timed modes of ventilation improved sleep quantity when compared with spontaneous modes of ventilation (SMD, 0.45; 95% CI, 0.10-0.81; P = .01). Nonmechanical ventilation interventions tended to improve sleep quantity (SMD, 0.65; 95% CI, −0.03 to 1.33; P = .06) and to reduce sleep fragmentation (SMD, −0.29; 95% CI, −0.61 to 0.03; P = .07).

Conclusions

The synthesized evidence suggests that both mechanical ventilation- and nonmechanical ventilation-based therapies improve sleep quantity and quality in critically ill patients, but the clinical significance is unclear. In the future, adequately powered multicenter RCTs involving pharmacologic interventions to promote sleep in critically ill patients are warranted.

El texto completo de este artículo está disponible en PDF.

Keywords : Artificial respiration, Critical care, Critical illness, Hypnotics and sedatives, Polysomnography, Positive-pressure respiration, Sleep


Esquema


 Funding: This work was supported by National Institutes of Health (NIH) Grant 5R01HL095748 and Patient-Centered Outcomes Research Institute Grant IHS-1306-2505 to SP. During the writing of this article, SP was supported by NIH Grants HL095799 and CA184920. The funding institutions did not have any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
 Conflict of Interest: SP reports grants from the NIH and National Heart, Lung, and Blood Institute (HL095748 and HL095799), grants from Patient-Centered Outcomes Research Institute (IHS-1306-2505), grants from the U.S. Department of Defense (PT130770), grants from the NIH National Cancer Institute (CA184920), grants from the US Department of Army (PTO90825), grants from Johrei Institute, personal fees from the American Academy of Sleep Medicine, personal fees from the American College of Chest Physicians, nonfinancial support from National Center for Sleep Disorders Research of the NIH (National Heart, Lung, and Blood Institute) (HL095748 and HL095799), personal fees from USMLEWorld Inc, personal fees from UpToDate Inc, personal fees from Philips-Respironics, Inc, grants from Younes Sleep Technologies, Ltd, grants from Niveus Medical Inc, and grants from Philips-Respironics, Inc, outside the submitted work. In addition, SP has a patent pending, UA 14-018 U.S.S.N. 61/884,654; PTAS 502570970 (Home breathing device). These conflicts including the patent are unrelated to the topic of this article.
 Authorship: All authors had access to the data and played a role in writing this manuscript.


© 2015  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 128 - N° 10

P. 1126 - octobre 2015 Regresar al número
Artículo precedente Artículo precedente
  • Reducing Prescribing Errors Through Creatinine Clearance Alert Redesign
  • Brittany L. Melton, Alan J. Zillich, Scott A. Russell, Michael Weiner, M. Sue McManus, Jeffrey R. Spina, Alissa L. Russ
| Artículo siguiente Artículo siguiente
  • Thrombotic Thrombocytopenia Purpura: A Potentially Reversible Cause of Complete Heart Block
  • Andrew Peters, Hayan Al Maluli, Mohammed Nayeemuddin, Arslan Mirza, Danesh Modi, Jeffrey Arkles, Riyaz Bashir

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.